1.

Introduction
Susac syndrome (SuS) is a rare disorder that is thought to be caused by autoimmune-mediated occlusions of microvessels in the brain, retina, and the inner ear, and is characterized by a clinical triad consisting of encephalopathy, branch retinal artery occlusion (BRAO), and hearing loss [1] . Typical findings in patients with SuS include BRAO detected on retinal fluorescein angiography (FA), characteristic lesions (corpus callosum spokes, icicles, and snowballs on sagittal T2; black holes in central fiber seen on sagittal T1; capsule microinfarctions associated with white matter infarcts and leptomeningeal involvement) [2] on brain magnetic resonance imaging (MRI), and evidence of sensorineural hearing loss [3, 4] . Due to multiple organ involvement and the absence of the classical clinical triad in the majority of cases at disease presentation, SuS often remains underdiagnosed, delaying the initiation of appropriate treatment [3, 5] . The prevalence of SuS is unclear, and there were 304 cases of SuS reported worldwide [3] . Some authors estimated the prevalence rate of SuS at 0.14 cases per 100,000 population in the Central European population [6] . In Lithuania, the incidence rate of SuS is unclear because not a single case report has been published until now, and only solitary cases were diagnosed. Encephalopathy commonly is recognized as the initial manifestation of SuS and is associated with headache, psychiatric disorders (behavioral changes or cognitive impairment), and focal neurological symptoms [7] . Headache occurs in about 80% of the patients with SuS [3] . The proposed diagnostic criteria of the European Susac Consortium (EuSaC) acknowledge headache as a possible brain manifestation if it is new, described as migrainous or oppressive, and precedes the other symptoms by not more than 6 months [4] . Brain MRI, retinal FA, and audiometry are required tests for SuS diagnosis [3, 8] . Due to the lack of randomized clinical trials, the treatment of SuS is symptomatic and based on clinical experience [3] [4] [5] , but early immunosuppressive strategy is recommended [2] . It has been noticed that multiple sclerosis disease-modifying treatment is not effective and could deteriorate the neurological condition [9, 10] .
In this paper, we discuss three cases of patients who presented with different characteristics of headache associated with SuS.
2.
Presentation of cases
Case 1
A 26-year-old woman with a history of rare migraine attacks from 15 years of age presented at the Emergency department when she experienced a sudden onset of an episode of diplopia that lasted for 30 min after 1 month of everyday migraine-like headache attacks (headache characteristics are described in Table 1 ; according to the ICHD-3 criteria). No specific treatment for headache was prescribed. Episodes of diplopia subsequently recurred several times during the period of a few days. Two weeks from the first episode of diplopia, the patient suddenly lost hearing in the left ear. Audiometry revealed left-sided sensorineural hearing disturbance. She was diagnosed with acute cochlear neuritis and was treated with glucocorticoids and hyperbaric oxygen therapy, which resulted in partial clinical improvement. One month later, the patient experienced an acute attack of somnolence, confusion/disorientation, vertigo, nausea, slurred speech, and hearing loss in the right ear, and was admitted to the Department of Neurology of our Hospital. Following an extensive diagnostic work-up, demyelinating disorders, vascular disorders, and chronic infections were ruled out, and the patient was diagnosed with SuS according to the diagnostic criteria of the EuSaC (all clinical presentations and diagnostic tests are shown in Table 2 ). The patient received treatment with high-dose glucocorticoids that was partly effective, and oral prednisolone was continued; headache attacks decreased, although sensorineural hearing loss in the right ear and slight ataxia remained. During the last 3 years of follow-up, no new bouts of SuS were suspected. Due to persistent deafness, the cochlear implantation in the right ear was performed. At this time, migraine attacks repeat 1-2 times a month, as it was before the manifestation of SuS.
Case 2
A 40-year-old woman with no past history of headache first presented at the Department of Neurology of our Hospital 1 year before due to an intensive headache attack that was followed by diplopia and vertigo of approximately 20 min in duration. Headache mostly affected the upper part of her head bilaterally, was of pulsating quality, and was associated with nausea and intensive tinnitus. Intensive headache lasted less than an hour, and then slowly diminished. The diagnosis of probable migraine with an aura was made. After the manifestation of the first headache episode, the patient started experiencing severe attacks of bifrontal headache 2-3 times a month lasting from 2 to 12 h and accompanied by nausea, photophobia and phonophobia, and avoidance of physical activity (the characteristics of the headache are described in Table 1 according to the ICHD-3 criteria). These headache attacks were alleviated with analgesics. Two months later, the patient experienced an episode of hemiparesis and hemihypesthesia accompanied by vertigo and balance disturbance. Due to suspected multiple sclerosis, the patient was treated with high doses of glucocorticoids, which resulted in clinical improvement; for maintenance, oral steroids were prescribed, and headache attacks decreased. Her migraine-like headache attacks repeated frequently for several months, and then gradually disappeared. A year later, such symptoms as balance impairment, hearing difficulty (mostly affecting the right ear), and diplopia appeared, and hypoesthesia and hemiparesis recurred. The patient was hospitalized in our department for further investigations for the second time. MS, vascular disorders, and chronic infections were ruled out, and the patient was diagnosed with SuS according to the diagnostic criteria of the EuSaC (Table 2 ). High doses of intravenous glucocorticoids were prescribed, which resulted in a significant clinical improvement, and immunosuppressive treatment was started subsequently. Currently, the patient has no complaints of headache.
Case 3
A 55-year-old woman with a history of migraine-like headache attacks from 14 years of age was admitted to our department for the revision of the diagnosis and the suspicion of SuS. After comprehensive clinical and diagnostic tests, the diagnosis of SuS was confirmed ( Table 2) . The anamnesis data showed that at 15 years of age, she suddenly lost hearing, which was immediately followed by an increase in the frequency of headache attacks to 5-6 times/ month (the characteristics of the headache are described in Table 1 , according to the ICHD-3 criteria [11] ). Audiometry revealed bilateral sensorineural hearing disturbance, and thus bilateral cochlear neuritis was diagnosed at that time. Hearing loss persisted, and one year later, she received a right side cochlear implant, which she is still using.
At 47 years of age, she experienced an episode of confusion, disorientation, memory loss, speech disturbance, ataxia, and visual disturbances (short episodes of blurring and flashing) that lasted 4 h. This clinical episode was diagnosed as a transient ischemic attack. A few months later, brain MRI revealed similar to demyelinating lesions in the periventricular area and in the brainstem. The diagnosis of MS was suspected, and treatment with high doses of prednisolone was started, which resulted in clinical improvement. The patient received disease-modifying treatment, which was ineffectivethe patient did not tolerate the treatment, and thus it was discontinued. Maintenance treatment with glucocorticoids 2 0 1 7 ) 4 2 0 -4 2 5 was prescribed, and later on, the frequency of headache dropped to a few times per month. After 6 years, the patient again experienced vertigo, ataxia, and visual disturbance, and was hospitalized in our department. Brain MRI was repeated, and small white matter lesions including the corpus callosum were found (Fig. 1) . The diagnosis was reviewed and, according to the diagnostic criteria of the EuSaC (Table 2) , SuS with residual symptoms and migraine without aura was confirmed.
No specific treatment for migraine was prescribed. At this time, headache occurs 1-2 times per month. During the last 1-year follow-up, no new bouts of SuS have occurred.
Discussion
We report three cases of SuS associated with headache. Our patients experienced different presentations of migraine-like headache in relation with the manifestation of SuS.
Headache is a common symptom of SuS, affecting up to 80% of SuS patients [3] . Although the proposed diagnostic criteria of the European Susac Consortium (EuSaC) acknowledge headache as a possible brain manifestation if it is new, described as migrainous or oppressive, and precedes the other symptoms by not more than 6 months [4] , these headache characteristics are not yet approved as actual diagnostic criteria of the SuS.
All our patients experienced migraine-like headache that was of severe intensity and was responsive to analgesics (the characteristics of the headache are shown in Table 1 ). In the first two cases, the manifestation of SuS started with visual symptoms in relation with headache, which later were followed by other SuS symptoms. In the diagnostics of SuS, especially in its manifestation, it can be difficult to tell apart a migrainous visual aura from visual symptoms relating to branch retinal artery inflammation.
With regards to the clinical course of SuS in relation to headache, our patients experienced three types of migrainelike headache: (1) exacerbation and chronification of migrainelike headache one month before the manifestation of SuS; (2) migraine-like headache preceded the manifestation of other SuS symptoms; (3) migraine-like headache increased in frequency after SuS (clinical presentations are shown in Table 3 ). According to literature [3, 4, 7] , headache is a common symptom during the initial manifestation of SuS, but there is a lack of information about the associations, intensity, quality and profile of SuS-related headache in relation with the course of SuS. SuS is a rare disorder that affects the brain, ears, and eyes. It often remains undiagnosed due to multiple system involvement imitating other disorders, which prolongs time to diagnosis. In all of our patients, MS was suspected at first. However, it is important to distinguish SuS from MS. Focal neurologic symptoms and signs are not helpful for the differential diagnosis because both conditions can affect any area of the central nervous system and cause similar symptoms [3, 12] . Hearing loss, vertigo, and tinnitus could also be found in MS, but they are not permanent. Bilateral hearing loss and tinnitus are not common for MS, thus leading to the diagnosis of SuS or other diagnoses [12] . Visual symptoms due to optic neuritis are common in MS, but changes in fluorescein angiography are more common in SuS [8] . Optic coherence tomography could also be helpful in distinguishing SuS from MS [13] [14] [15] . Together with headache, encephalopathy (cognitive impairment, confusion, and disorientation) is considered to be one of the most frequent manifestation of SuS [3] . At the onset or during the course of the disease, all our patients experienced episodes of confusion, disorientation, and behavioral changes, which were mistakenly attributed to panic or transient ischemic attacks. Headache and the symptoms of encephalopathy are very rare in MS and could be helpful in differential diagnosis [12, 16] . The pathophysiology of SuS is not clear, but so far it has been thought to be immune-mediated endotheliopathy [17] . It was suggested that anti-endothelial antibodies cause endothelial changes leading to occlusions in small microvessels and thus to small infarcts in the brain, retina, and cochlea [5] . Headache is most likely the result of leptomeningeal vessel damage [17] . Endothelial changes are typical for anti-endothelial antibody-mediated injury [5] . However, recently, based on 3 patients' experience and the results of brain biopsy, Hardy et al. suggested a T-cell-mediated inflammatory contribution to lesion pathogenesis of SuS [18] . Brain biopsy sampling revealed T-cell inflammation in small-and medium-sized vessels [18] . It is difficult to distinguish whether humoral immunity or cellular mechanisms play a role in disease pathogenesis. For the evaluation of anti-endothelial antibodies and their role in SuS pathogenesis, further serological studies are required [19] . More histopathological studies need to be performed to clarify the cellular mechanism, considering disease duration, lesion location, and treatment [18] .
The proposed diagnostic criteria of the EuSaC acknowledge headache as a possible brain manifestation if it is new, described as migrainous or oppressive, and precedes the other symptoms by not more than 6 months [4] . The three cases presented in our paper have shown that there can be different presentations of migraine-like headache in relation to the manifestation of SuS.
This statement needs further analysis of more patients with SuS focusing on the relationship of headache with the manifestation and the course of the disease in order to improve the understanding of the characteristics of headache in relation to the syndrome.
Conclusions
Based on the results of our analysis, we conclude that migraine-like headache as a symptom of SuS could have different presentations in relation to the manifestation of SuS: exacerbation and chronification of headache just before the manifestation of the first symptoms of SuS, the manifestation of migraine-like headache during the first episode of the syndrome, and an increasing frequency of headache during the course of the disease. We suggest that further analysis of SuS cases should focus more on the characteristics of headache in relation to the manifestation of SuS as well as other symptoms of this syndrome.
